181 related articles for article (PubMed ID: 34560682)
21. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
[TBL] [Abstract][Full Text] [Related]
22. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
[TBL] [Abstract][Full Text] [Related]
24. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
[TBL] [Abstract][Full Text] [Related]
25. [Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].
Anlauf M; Perren A; Klöppel G
Verh Dtsch Ges Pathol; 2007; 91():320-9. PubMed ID: 18314630
[TBL] [Abstract][Full Text] [Related]
26. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.
Conemans EB; Brosens LAA; Raicu-Ionita GM; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Timmers HTM; Offerhaus GJ; Valk GD; Vriens MR
Pancreatology; 2017; 17(5):766-772. PubMed ID: 28811081
[TBL] [Abstract][Full Text] [Related]
28. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
[TBL] [Abstract][Full Text] [Related]
30. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
[TBL] [Abstract][Full Text] [Related]
31. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
[TBL] [Abstract][Full Text] [Related]
34. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
35. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
36. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.
Anlauf M; Perren A; Henopp T; Rudolf T; Garbrecht N; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
Gut; 2007 May; 56(5):637-44. PubMed ID: 17135306
[TBL] [Abstract][Full Text] [Related]
37. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
38. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
